Join us at the Premier Event for the Products Liability and MDL Defense Bar.
Network and benchmark on the latest multi-district litigation strategies with 400+ pharmaceutical and device litigators, private practice attorneys and Judges hearing these matters.
2024 Conference Co-Chairs
Eileen M. Hunter
Vice President
Head of Global Litigation
Boston Scientific
Christiana Jacxsens
Deputy General Counsel
B. Braun Medical Inc.
Renowned Jurists
Honorable Karen K. Caldwell
Chief Judge
U.S. District Court, E.D. Kentucky (Chair, Judicial Panel on Multidistrict Litigation [JPML])
Honorable Brian H. May
Circuit Judge, Division 1
St. Louis County Circuit Court
Featured Speakers
Adam Bassing
Head of Global Litigation
UCB, Inc.
Lisa A. Dunkin
Vice President & Associate General Counsel, Litigation
Zimmer Biomet
Rachel Gallagher
Associate General Counsel
Teleflex Inc.
Amy Todd Klug
General Counsel and Secretary, Head of Legal and Corporate Affairs
Daiichi Sankyo, Inc.
Leah Lorber
Assistant General Counsel
GSK
Richard W. Silbert
Vice President, Legal Strategy & Public Health Initiatives
Purdue Pharma L.P.
Complimentary Webinar
Implications of the Latest Rulings, Settlements and Evidentiary Amendments to Drug and Medical Device Litigation: A View from In-House Practitioners
Thursday, September 26
1:00 pm – 2:00 pm
What’s NEW for 2024
Interactive Audience Polling
Provide input during these real-world case studies and in-depth strategy discussions with leading industry practitioners.
Case Study to Explore the Capabilities of AI in Analyzing Legal Proceedings
An AI tool and a Law Firm Senior Associate will examine a product liability Complaint and decide next steps for pleadings, client advisement and resolution strategies – audience will vote on the strategies.
The End of Chevron Deference
Leading Supreme Court practitioners will guide a critical discussion on the current and future impact of the Supreme Court’s Loper Bright ruling.
Developing and Implementing Exit Strategies to Conclude Drug and Device Litigation
Addressing best practices for developing and implementing effective exit strategies and identifying common challenges in product liability settlements.
Key Insights from Groundbreaking Rulings
An exploration of the year’s biggest cases based on novel and non-traditional plaintiff theories.
Navigating the New Rule 702 Amendments
Seasoned litigators discussing ways to leverage the amendments and transform how expert testimony is assessed.
Benefit from our Pre-Conference Working Groups
Each working group offers 3.5 hours of dynamic and in-depth discussions on the essential components of effective MDL defense strategies, featuring insights from both in-house and outside counsel perspectives.
Working Groups are offered In-Person only.
Working Group AMastering MDL Defense: Strategic Approaches to Overcome Complex Challenges and Dismiss Meritless Claims
December 2, 2024
9:00 am – 12:30 pm
Working Group BDemystifying and Defeating Junk Science in the Courtroom: Techniques to Identify and Challenge Unreliable Evidence
December 2, 2024
1:30 pm – 5:00 pm
Network and Benchmark with Representatives from Leading Drug and Medical Device Companies Including:
- Bayer Corporation
- Beckton Dickinson and Company
- Boehringer Ingelheim
- Bristol Myers Squibb
- Boston Scientific
- Daiichi Sankyo
- Endo Pharmaceuticals
- Genentech
- GlaxoSmithKline
- Johnson & Johnson
- Medtronic
- Nuvasive
- Olympus Corporation
- Purdue Pharma
- Smith & Nephew
- Solventum
- Teleflex Inc.
- UCB Inc.
- Viatris
- WL Gore & Associates Inc.
- Zimmer Biomet
The Premier Event for the Products Liability and MDL Defense Bar!
400+
Attendees
20
Content-Rich
Panel Discussions
70+
Speakers
Including More Than 30 In-House Counsel from Leading Life Sciences Companies
3
Full Days of
Extended Networking
Sponsorship Opportunities
With conferences in the United States, Europe, Asia Pacific, and Latin America, the C5 Group of Companies: American Conference Institute, the Canadian Institute, and C5 Group, provides a diverse portfolio of conferences, events and roundtables devoted to providing business intelligence to senior decision makers responding to challenges around the world.
Don’t miss the opportunity to maximize participation or showcase your organizations services and talent. For more information, please contact:
Aaron Goldstein | [email protected]
“There is no better forum for leading edge thinking on today’s most pressing drug and med litigation challenges.”
“Great agenda and networking opportunities.”
“It was good to see a panel of judges that are familiar with the JPML and MDLs, as well as state coordinated proceedings, and who are currently presiding over some of the largest mass torts.”
“ACI’s Drug & Medical Device Conference is THE must attend, premier conference for attorneys practicing in the drug and medical device space.”
“…for almost 20 years. I try not to miss [this event] because I find it is a valuable way to learn about developments in the products field. Of course, it is also always great to catch up with in-house peers, outside counsel and to also meet new colleagues.”
“I look forward to the ACI Drug and Med Conference every year as I’m sure to find helpful discussion on current topics that matter to me as well as a balanced outlook from both in-house and outside counsel.”
